Bogin

What Bogin does

Bogin (legal name: Biosimilars en generieke geneesmiddelenindustrie Nederland) is a Dutch industry association founded in 1987 and headquartered in The Hague. It is the sole trade body representing biosimilars and generic medicines manufacturers in the Netherlands, with a current membership of seven companies: Aurobindo, Centrafarm, Disphar International, PharmaMatch, Sandoz, TEVA Pharmachemie, and Viatris. Collectively, Bogin's members supply over 90% of all generic medicines and biosimilars in the Dutch market by both value and volume.

The organization functions as an advocacy body (belangenorganisatie), engaging with the Dutch government, health insurers, and other healthcare stakeholders on policy issues including medicine availability, shortages, affordability, preferentiebeleid (preference policy), and Falsified Medicines Directive compliance. Bogin also engages in public education via its website, newsletters (Bogin Bericht), and social media channels, and participates in international advocacy through its memberships in Medicines for Europe (since 1987) and IGBA (since 1997). It does not manufacture or sell products; its operating model is funded by member companies and its secretariat comprises 1-10 staff.

Governance is led by a chairman; Jean M. Hermans has served as voorzitter since April 1, 2019, succeeding Martin L.A. Favié. The association has been active continuously since founding, with periodic member changes (e.g., Centrafarm joining in 2015) and ongoing public positioning on Dutch healthcare policy matters.

Name

Bogin

Legal name

Biosimilars en generieke geneesmiddelenindustrie Nederland

Website

https://www.bogin.nl

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

1–10 employees

Short description

Bogin is the Dutch trade association founded in 1987 that represents seven biosimilars and generic medicines manufacturers, whose members collectively supply over 90% of generic medicines and biosimilars in the Netherlands.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Association

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Generic medicines association
• Biosimilars industry advocacy
• Pharmaceutical trade association
• Generic drug manufacturers
• Biosimilar medicines industry

Headquarters

HQ city

The Hague

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Marketing channels5 records

Core offering

Bogin is the Dutch trade association (belangenorganisatie) for biosimilars and generic medicines manufacturers, founded in 1987. It represents seven member companies (Aurobindo, Centrafarm, Disphar International, PharmaMatch, Sandoz, TEVA Pharmachemie, and Viatris) that collectively supply over 90% of generic medicines and biosimilars in the Netherlands. The organization advocates for the collective interests of its members in healthcare policy discussions with government, health insurers, and other stakeholders, and provides informational resources on biosimilars and generic medicines.

Product overview

Bogin (Biosimilars en Generieke Geneesmiddelenindustrie Nederland) is a trade association representing biosimilars and generic medicines manufacturers in the Netherlands, founded in 1987. It is not a product company but rather an industry organization that advocates for the interests of its seven member companies: Aurobindo, Centrafarm, Disphar International, PharmaMatch, Sandoz, TEVA Pharmachemie, and Viatris. The association provides informational resources about generic medicines and biosimilars, publishes industry news, and engages with policy makers on healthcare affordability and availability.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Members supply over 90% of generic medicines and biosimilars in the Netherlands

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core, member and former member.

• IGBA (International Generic and Biosimilar Medicines Association)coreStrategic or Co-development Partner · 1 January 1997IGBA (International Generic and Biosimilar Medicines Association) was established in 1997 and consists of Medicines for Europe, CGPA, GPhA, IPA, TGPA, JAPM, JGA, PróGenéricos, NAPM, AGEGI, and GBMA. IGBA works to promote international pharmaceutical harmonization and regulation that benefits the general public and strengthens the generic industry position. IGBA maintains contacts with organizations in Latin America and serves as the official representative of the generic industry in ICH, WHO, and other international organizations. Headquarters: Rue d'Arlon, 50, B-1000 Brussels, Belgium.
• Medicines for Europe (MFE)coreStrategic or Co-development Partner · 1 January 1987Medicines for Europe (formerly EGA - European Generic medicines Association) is the European umbrella organization representing generic, biosimilar and value added medicines industries. BOGIN is the Dutch member. MFE represents over 350 manufacturing and R&D sites across Europe, employing over 160,000 people and investing up to 17% of turnover in R&D. Their portfolio covers 80% of therapy areas and supplies the majority of all prescribed medicines in Europe. Generic medicines account for 56% of all dispensed medicines but only 22% of pharmaceutical expenditure.
• Aurobindo Pharma Ltd.memberOthersAurobindo Pharma Ltd. is a globally leading pharmaceutical company specializing in development of active substances, prescription and OTC medicines. With over 23,000 employees across four continents with representation in 155 countries, Aurobindo focuses on generic medicines and provides high-quality affordable healthcare. In the Netherlands, Aurobindo supports pharmacies, wholesalers, hospitals, drugstores, supermarkets, and pharmacy-holding doctors in providing optimal patient care with a broad assortment, favorable commercial terms, and continuous attention to quality. Address: Baarnsche Dijk 1, 3741 LN BAARN, Netherlands.
• CentrafarmmemberOthersCentrafarm has an extensive range of generic medicines supplied through pharmaceutical wholesalers to pharmacies, pharmacy-holding doctors, and hospitals in the Netherlands. Since 1991, Centrafarm is a wholly-owned subsidiary of the listed multinational STADA. As a member of the STADA group, Centrafarm is part of a successful global network. Address: Van de Reijtstraat 31-E, 4814 NE Breda, Netherlands.
• Disphar International BVmemberOthersDisphar International is a dynamic and fast-growing company providing state-of-the-art Pharmaceutical Services to over 100 pharmaceutical companies within and outside the European Union. Disphar has built a strong reputation as developer and supplier of generic pharmaceuticals and innovative drug formulations, outstanding registration dossiers and high quality finished products. Its customer base includes leading companies in both the innovative as well as the multi-source pharmaceutical industry. Currently employs 35 highly skilled professionals with locations in Baarn, Hengelo (Gld), and Mumbai (India). Member of the Nordic Group, a fast growing, full-service Pan-European pharmaceutical company. Address: Postbus 17, 3740 AA BAARN, Netherlands.
• PharmaMatch BVmemberOthersPharmaMatch is a successful, globally operating group of companies, founded in 2000 by Jair Eisenmann and Lodewijk Moens. The organization has grown to over 40 employees with offices in the Netherlands, Switzerland, Greece, India, and Canada. Address: Van Boshuizenstraat 12, 1083 BA Amsterdam, Netherlands.
• SandozmemberOthersSandoz is the world market leader in production and supply of generic medicines. In the Netherlands, Sandoz has its location in Almere. The headquarters of Sandoz is located in Holzkirchen, Germany. Due to its international character, Sandoz Nederland can start development of new generics at an early stage. The size of the company enables investment in research, as well as supplying medicines with less demand. Core values of Sandoz are: quality, globally active, innovative. Address: Veluwezoom 22, 1327 AH ALMERE, Netherlands.
• TEVA Pharmachemie BVmemberOthersTEVA Pharmachemie has been part of Teva Pharmaceutical Industries Ltd. since 1998, the world's largest supplier of generic medicines. Teva is an Israeli family business that celebrated its 100-year anniversary in 2001. Besides its leading position in the global generic medicines market, Teva is also active in the pharmaceutical raw materials market and innovative medicines. Within Teva, Pharmachemie, through its commercial company Teva Nederland, is responsible for the Dutch market. TEVA Pharmachemie Operations is the producer and supplier of products for the treatment of cancer and asthma/COPD for Teva subsidiaries worldwide. Address: Swensweg 5, 2031 GA HAARLEM, Netherlands.
• ViatrismemberOthersViatris in the Netherlands enables people around the world to live a healthier life in every phase of their lives. In the Netherlands, they are one of the largest suppliers of high-quality medicines. Viatris has a broad assortment of medicines consisting of brand and generic medicines, biosimilars, and OTC medicines. In the Netherlands, operates under the name Mylan BV. Address: Krijgsman 20, 1186 DM Amstelveen, Netherlands.
• Apotex Nederland BVformer memberOthersApotex Nederland BV is part of Apotex, Canada's largest pharmaceutical company. In April 2004, Apotex acquired Katwijk Farma. In 2008, the name was changed to Apotex Nederland BV. Apotex brings a wide range of prescription and non-prescription medicines to market. Address: Bio Science Park, Archimedesweg 2, 2333 CN Leiden, Netherlands. Note: Apotex is listed on the links page and mentioned in press releases about past BOGIN symposia, suggesting former membership.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Medicines for Europe: European umbrella trade association for the generic, biosimilar and value-added medicines industry, representing 350+ manufacturing sites and 160,000 employees. Bogin is a direct Dutch member, making this its closest peer in mission, structure, and stakeholder engagement.
• International Generic and Biosimilar Medicines Association (IGBA): Global umbrella association for generic and biosimilar medicines manufacturers, of which Bogin is a member via its affiliated national bodies. Comparable in advocacy scope and regulatory-cooperation function at the international level.

Regional players

• AAM (Association for Accessible Medicines): US trade association representing generic and biosimilar manufacturers, providing policy advocacy and regulatory engagement. Highly comparable mission and operating model to Bogin, but operating in the US market rather than the Netherlands.
• Pro Generika: German trade association for generic medicines manufacturers. Direct structural analogue to Bogin at the national level, sharing mandate, member profile, and policy-advocacy function, but serving Germany rather than the Netherlands.
• BGMA (British Generic Manufacturers Association): UK trade association representing manufacturers of generic medicines. Comparable advocacy function and member profile, but operating in the UK market rather than the Netherlands.
• CGPA (Canadian Generic Pharmaceutical Association): National trade association for Canada's generic pharmaceutical industry. Peer in mandate and membership structure, but serving the Canadian market and policy environment.
• GPhA (Generic Pharmaceutical Association, Japan): Japan Generic Medicines Association, a national trade body for generic pharmaceutical manufacturers. Sister organization within the IGBA umbrella, comparable in mission but focused on the Japanese market.

Others

• Sandoz: World market leader in generic medicines and a Bogin member. Not a direct peer organizationally but is the dominant generic manufacturer within Bogin's membership and representative of the type of manufacturer the association serves.
• Teva Pharmaceutical Industries: World's largest generic medicines supplier and Bogin member via TEVA Pharmachemie BV. Represents the multinational manufacturer constituency Bogin represents and is a key stakeholder shaping the association's agenda.
• Viatris: Global generics and biosimilars manufacturer operating in the Netherlands under the Mylan BV name and listed as a Bogin member. Constitutes one of the principal manufacturers within Bogin's collective representation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/BoginGeneriek
• YouTubeyoutube.com/channel/UCJ-aNz9qHAHM4O5D-tZtqvQ
• LinkedInlinkedin.com/company/bogin

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bogin